Whole genome sequencing of 4,787 individuals identifies gene-based rare variants in age-related macular degeneration

Hum Mol Genet. 2024 Feb 1;33(4):374-385. doi: 10.1093/hmg/ddad189.

Abstract

Genome-wide association studies have contributed extensively to the discovery of disease-associated common variants. However, the genetic contribution to complex traits is still largely difficult to interpret. We report a genome-wide association study of 2394 cases and 2393 controls for age-related macular degeneration (AMD) via whole-genome sequencing, with 46.9 million genetic variants. Our study reveals significant single-variant association signals at four loci and independent gene-based signals in CFH, C2, C3, and NRTN. Using data from the Exome Aggregation Consortium (ExAC) for a gene-based test, we demonstrate an enrichment of predicted rare loss-of-function variants in CFH, CFI, and an as-yet unreported gene in AMD, ORMDL2. Our method of using a large variant list without individual-level genotypes as an external reference provides a flexible and convenient approach to leverage the publicly available variant datasets to augment the search for rare variant associations, which can explain additional disease risk in AMD.

Keywords: aging; genetic variation; genome-wide association study; macular degeneration; vision loss; whole genome sequencing.

MeSH terms

  • Complement Factor H / genetics
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Genome-Wide Association Study* / methods
  • Genotype
  • Humans
  • Macular Degeneration* / genetics
  • Polymorphism, Single Nucleotide / genetics
  • Whole Genome Sequencing

Substances

  • Complement Factor H